A FRAX-derived 10-year major osteoporotic fracture probability of 22% indicates how should management proceed?

• A. No pharmacologic therapy is needed at this time.
• B. Indicates elevated fracture risk; pharmacologic treatment is typically recommended after evaluating patient preferences and guidelines.
• C. Only lifestyle modifications are necessary.
• D. Immediate surgical intervention is required.

Answer: (B)

A FRAX result of 22% for a 10-year major osteoporotic fracture means the person has elevated fracture risk and should be considered for pharmacologic treatment rather than relying on lifestyle changes alone.

FRAX combines several risk factors (age, sex, body size, prior fracture, smoking, alcohol, glucocorticoid use, secondary osteoporosis conditions, and rheumatoid arthritis) and can include bone density data to estimate the probability of a major osteoporotic fracture. When the estimated risk is around or above 20%, guidelines commonly support discussing osteoporosis medications with the patient and proceeding with treatment if there are no strong contraindications and the patient agrees. This approach aims to reduce the likelihood of future vertebral, hip, and other osteoporotic fractures.

In practice, management would involve shared decision-making: informing the patient about the potential benefits and risks of pharmacologic therapy (such as bisphosphonates, denosumab, or other agents), and then initiating treatment if appropriate. The plan should also include optimizing calcium and vitamin D intake, addressing modifiable fall risk factors, and confirming or measuring bone density as part of a comprehensive assessment.

Immediate surgical intervention is not appropriate for preventing fractures, and relying on lifestyle changes alone would not align with the level of risk indicated by a 22% FRAX probability.